Opinion: 2022 could be the year for pharmaceutical marijuana
Despite the success of adult-use marijuana, 2022 is looking like the year pharmaceutical cannabis becomes a major market…
News March 21Despite the success of adult-use marijuana, 2022 is looking like the year pharmaceutical cannabis becomes a major market…
News March 21Two Canadian medical cannabis producers received European Union-Good Manufacturing Practice (GMP) certification, an essential step to exporting cannabinoids…
News March 9The Kanabo Group is banking on potential growth to correct its stock trend, and how to best use…
News March 2A Dutch lighting giant signed a definitive agreement to acquire Texas-based Fluence, which provides grow lights to cannabis…
News December 20German pharmaceutical manufacturer Dermapharm Holding SE has struck a deal to buy C3 Cannabinoid Compound Co. GmbH from…
News December 15Maltese lawmakers approved a landmark bill that decriminalizes some quantities of recreational cannabis, regulates home cultivation and permits…
News December 14The three parties expected to form the next government in Germany have agreed to regulate the distribution and…
News November 24Edmonton, Alberta-based Aurora Cannabis saw its net loss improve to 11.8 million Canadian dollars ($9.5 million) in its…
News November 9Edmonton, Alberta-based Aurora Cannabis is investing "a significant equity stake" in upstart Netherlands-based Growery B.V., one of only…
News November 9Venture capital firm Casa Verde Capital invested $3.5 million (3 million euros) in Berlin-based cannabis startup Sanity Group.
News November 3